Diagnosis and Therapy of Skin Neoplasms

Skin cancer is the most common neoplasm worldwide, with squamous cell carcinoma and basal cell carcinomas being the most frequent. Moreover, cutaneous melanoma is one of the most aggressive neoplasms in human pathology, and its incidence has been increasing in the last decades. Consequently, a correct and early diagnosis is essential for the best clinical management of the patient and for the best prognosis. However, the diagnosis of skin cancer offers particular difficulties, and consequently requires an integrative approach including both dermatologist and pathologist. Moreover, different therapeutic strategies may be currently offered to the skin cancer patients, depending on the stage of the neoplasm and the expression of specific therapeutic targets by neoplastic cells.

The multidisciplinary approach has recently acquired an important role in several branches of medicine including dermatology and dermatopathology, as the discussion between different medical specialists may lead to the best management of the patients, for both diagnostic and therapeutic purposes. Indeed, tumor board meetings provide the opportunity to evaluate the diagnosis and the treatment possibilities, favoring adherence to the clinical guidelines, and improving communication among medical specialists. In this view, multidisciplinary management represents an essential guarantee for both the correct diagnosis and optimal treatment. Although every single specialist tends to have specific skills within their own specialty, multidisciplinary management represents an essential guarantee for both the correct diagnosis and optimal treatment of patients with cutaneous neoplasms.
 

How we work:

• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
• A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
• Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

Media Contact:
Nimmi Anna
Journal Manager
Allied Journal of Medical Research
Email: medicalresearch@emedsci.com
https://www.alliedacademies.org/allied-journal-of-medical-research/